Live Breaking News & Updates on Versiti Blood Research Institute

Stay updated with breaking news from Versiti blood research institute. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ponatinib Showcases Long-Term Efficacy, Safety in CP-CML With T315I Mutations

Ponatinib generated long-term efficacy and displayed manageable safety in chronic-phase chronic myeloid leukemia harboring a T315I mutation. ....

United States , Michael Deininger , Versiti Blood Research Institute , Closer Look ,